Disturbances of Basal and Postprandial Insulin Secretion and Clearance in Obese Patients with Type 2 Diabetes Mellitus

被引:10
|
作者
Erdmann, J. [1 ,2 ]
Poehnl, K. [1 ]
Mayr, M. [2 ]
Sypchenko, O. [3 ]
Naumann, A. [4 ]
Wagenpfeil, S. [4 ]
Schusdziarra, V. [1 ,2 ]
机构
[1] Tech Univ Munich, Dept Med Nutr, D-81675 Munich, Germany
[2] Tech Univ Munich, Dept Internal Med 2, D-81675 Munich, Germany
[3] Univ Munich, Dept Math, Munich, Germany
[4] Tech Univ Munich, Dept Med Stat & Epidemiol, D-81675 Munich, Germany
关键词
insulin secretion; insulin resistance; body weight; obesity; BETA-CELL RESPONSIVENESS; FASTING PLASMA-GLUCOSE; 5-YEAR FOLLOW-UP; SERUM-INSULIN; INTRAVENOUS GLUCOSE; WEIGHT-LOSS; LIVER FAT; RESISTANCE; TOLERANCE; NIDDM;
D O I
10.1055/s-0031-1295414
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hyperinsulinemia of nondiabetic overweight and obese subjects is associated with weight-dependent increased insulin secretion and decreased insulin clearance. The present analysis examines whether similar effects can be observed in overweight and obese patients with type 2 diabetes mellitus (DM2). Additionally basal and postprandial insulin secretion and clearance were analyzed in relation to duration of disease. In a random sample of 348 DM2 patients basal plasma insulin concentrations were significantly higher in most BMI groups compared to matched nondiabetic (ND) controls. The weight-dependent increase of basal insulin in DM2 was primarily the result of reduced clearance rather than augmented secretion. Postprandial insulin concentrations were lower in DM2 patients and did not show any BMI-related increase. The weight-dependent reduction of postprandial insulin clearance was absent in DM2. At the time of diagnosis basal insulin concentration was higher and secretion was comparable to ND subjects and this did not change with duration of diabetes. The early postprandial insulin response was still comparable between DM2 and ND subjects at the time of diagnosis but deteriorated with longer duration of disease. The later postprandial response at diagnosis (AUC 90-180) was characterized by significantly greater insulin secretion and concentration while later on the 3-fold higher secretion was paralleled by comparable peripheral plasma concentrations due to a significantly greater postprandial insulin clearance in DM2. In conclusion, the present data indicate that apart from disturbances of insulin secretion substantial changes of insulin clearance contribute to inadequate peripheral insulin concentrations in obese DM2 patients.
引用
收藏
页码:60 / 69
页数:10
相关论文
共 50 条
  • [1] Early disturbances in insulin secretion in the development of type 2 diabetes mellitus
    van Haeften, TW
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 197 (1-2) : 197 - 204
  • [2] Basal Insulin Resistance and Secretion in Nigerians With Type 2 Diabetes Mellitus
    Oli, J. M.
    Adeyemo, A. A.
    Okafor, G. O.
    Ofoegbu, E. N.
    Onyenekwe, B.
    Chukwuka, C. J.
    Onwasigwe, C. N.
    Ufelle, S.
    Chen, G.
    Rotimi, C. N.
    [J]. METABOLIC SYNDROME AND RELATED DISORDERS, 2009, 7 (06) : 595 - 599
  • [3] Basal insulin requirement in insulin treated patients with type 2 diabetes mellitus
    Wiesli, P
    Lehmann, R
    Kraydenbühl, PA
    Schmid, C
    Spinas, GA
    [J]. DIABETES, 2005, 54 : A102 - A102
  • [4] Effect of glycine on insulin secretion, fasting and postprandial glucose levels in patients with Type 2 diabetes mellitus.
    Martínez-Abundis, E
    Kam-Ramos, AM
    Hernández-Salazar, E
    González-Ortiz, M
    [J]. DIABETOLOGIA, 2003, 46 : A261 - A262
  • [5] Initiating basal insulin therapy in patients with type 2 diabetes mellitus
    Stoneking, K
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2005, 62 (05) : 510 - 518
  • [6] Achieving postprandial glucose control with lixisenatide improves glycaemic control in patients with type 2 diabetes mellitus on basal insulin
    Paranjape, S.
    Stager, W.
    Berria, R.
    Leiter, L. A.
    [J]. DIABETOLOGIA, 2015, 58 : S383 - S383
  • [8] Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin
    Blak, B. T.
    Smith, H. T.
    Hards, M.
    Curtis, B. H.
    Ivanyi, T.
    [J]. DIABETIC MEDICINE, 2012, 29 (07) : E13 - E20
  • [9] Aminophylline stimulates insulin secretion in patients with type 2 diabetes mellitus
    Arias, AMP
    Bisschop, PH
    Ackermans, MT
    Nijpels, G
    Endert, E
    Romijn, JA
    Sauerwein, HP
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (09): : 1030 - 1035
  • [10] Indomethacin decreases insulin secretion in patients with type 2 diabetes mellitus
    Arias, AMP
    Romijn, JA
    Corssmit, EPM
    Ackermans, MT
    Nijpels, G
    Endert, E
    Sauerwein, HP
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 2000, 49 (07): : 839 - 844